Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Melanoma treatment details. Immunotherapy. University of Southern California, Los Angeles, CA, United States

Survival: ?
Toxicity Grade: 3
Treatments: Immunotherapy
Country: United States
City/State/Province: Los Angeles, CA
Hospital: University of Southern California
Journal: Link
Date: 4/2003

Patients: This Phase II study involved 15 patients with resected metastatic melanoma.

Treatment: The treatment consisted of a multipeptide vaccine administered with progenipoietin an agonist of granulocyte colony-stimulating factor.

Toxicity: There was one grade 3 neutropenia. Grade 1-2 toxicities included bone pain, fatigue, and nausea.

Results: The overal median survival was not reported.

Support: The study was supported by Pharmacia. This company manufactures or markets progenipoietin.

Correspondence: Jeffrey S. Weber, MD

E-mail to a Friend Email Physician More Information